PDCD1 and pachyonychia congenita: Most of the preclinical knowledge regarding the role of PD-L1 in PC and the effects of anti-PD-1/PD-L1 immunotherapy derived from experiments on immunocompetent mice, which received the injection of syngeneic mouse PC cells.